| 2-IB | 2-iminobiotin |
| 5-MTHF | 5-methyltetrahydrofolate |
| 5,10-Methylene-THF | 5,10-methylenetetrahydrofolate |
| 6-OHDA | 6-hydroxydopamine |
| ACC | Acetyl-CoA Carboxylase |
| ACE | Addenbrooke’s Cognitive Examination |
| ACE2 | Angiotensin-converting enzyme 2 |
| ACh | Acetylcholine |
| AChE | Acetylcholinesterase |
| AD | Alzheimer’s disease |
| ADHD | Attention-deficit hyperactivity disorder |
| Akt | Protein Kinase beta |
| AlCl3 | Aluminum chloride |
| ALS | Amyotrophic lateral sclerosis |
| AP-1 | Activator Protein 1 |
| APP | Amyloid precursor protein |
| ARE | Antioxidant Response Element |
| Aβ | Amyloid beta |
| ASD | Autism spectrum disorder |
| BACE1 | Beta-site APP cleaving enzyme 1 |
| BBB | Blood-brain barrier |
| BBGD | Biotin-responsive basal ganglia disease |
| BCCP | biotin carboxyl carrier protein |
| Bcl2 | B-cell lymphoma 2 |
| BDI | Beck Depression Inventory |
| BDNF | brain-derived neurotrophic factor |
| BH4 | tetrahydro-biopterin |
| BID | Twice daily |
| BV-2 | Brain 2 |
| CASI | Cognitive Abilities Screening Instrument |
| cAMP | Cyclic Adenosine Monophosphate |
| CAT | Catalase |
| CB | Cannabinoid receptors |
| CDR | Clinical Dementia Rating |
| c-FOS | cellular Finkel-Biskis-Jinkins murine osteogenic sarcoma virus |
| CNS | Central nervous system |
| COMPASS | Computerized mental performance assessment system |
| COMT | Catechol-O-methyltransferase |
| COX-2 | Cyclo-oxygenase-2 |
| CREB | cAMP response element-binding protein |
| CRP | C-reactive protein |
| CSD | cortical spreading depression |
| CVD | Cardiovascular disease |
| CVLT-II | California Verbal Learning Test-II |
| DALYs | Disability-adjusted life years |
| DNA | Deoxyribonucleic acid |
| EAHE | A-enriched Hericium erinaceus |
| ERK | Extracellular signal-regulated kinase |
| EU | European Union |
| FAAH | Fatty acid amide amidohydrolase |
| FTD | Frontotemporal dementia |
| FRA | Folate receptor autoantibodies |
| GABA | Gamma-aminobutyric acid |
| GDNF | Glial cell line-derived neurotrophic factor |
| GFAP | Glial fibrillary acidic protein |
| GPR119 | G protein-coupled receptor 119 |
| GPR55 | G protein-coupled receptor 55 |
| GPx | Glutathione peroxidase |
| GR | Glutathione reductase |
| GRP78 | Glucose-related protein 78 |
| GSH | glutathione |
| GSK-3 | Glycogen Synthase Kinase-3 |
| GSSG | Glutathione disulfid |
| GST | glutathione-S-transferase |
| HAT | Histone acetyltransferase |
| Hcy | Homocysteine |
| HDAC | Histone Deacetylase |
| HE | Hericium erinaceus |
| HEM | Hericium erinaceus mycelia |
| HEME | Hericium erinaceus mycelial extracts |
| HLCS | holocarboxylase synthetase |
| HO-1 | Heme oxygenase-1 |
| HPA | Hypothalamic–pituitary–adrenal |
| HT | Hydroxytyrosol |
| HupA | Huperzine A |
| IADL | Instrumental Activities of Daily Living |
| IGAP | Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders |
| IL-1α/β | Interleukin 1α/β |
| IL-6 | Interleukin-6 |
| iNOS | Inducible Nitric Oxide Synthase |
| IRE1α | Inositol-requiring transmembrane kinase/endoribonuclease 1α |
| IVIG | Intravenous immunoglobulin |
| JNK | c-Jun N-terminal kinases |
| KEAP1 | Kelch-like ECH-associated protein 1 |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-Activated Protein Kinase |
| MCC | Methylcrotonyl-CoA carboxylase |
| MCI | Mild cognitive impairement |
| MDA | malondialdehyde |
| MMSE | Mini-Mental State Examination |
| MPO | Myeloperoxidase |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| mRNA | messenger Ribonucleic Acid |
| MS | Multiple sclerosis |
| MTHFR | Methylenetetrahydrofolate reductase |
| NAPE | N-acylphosphatidylethanolamine |
| NF-κB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| NF-κB-p65 | Nuclear Factor kappa-light-chain-enhancer of activated B cells p65 subunit |
| NGF | Nerve growth factor |
| NLR | Neutrophil-to-lymphocyte ratio |
| NLRP3 | NLR family pyrin domain containing 3 |
| NMDA | N-Methyl-D-aspartic acid |
| NOS | Nitric oxide synthase |
| NEG2 | Nuclear factor erythroid 2-related factor 2 |
| NTDs | Neural tube defects |
| PC | Pyruvate Carboxylase |
| PCC | Propionyl-CoA Carboxylase |
| PD | Parkinson’s disease |
| PEA | Palmitoylethanolamide |
| PEALut | PEA and luteolin |
| PI3K | Phosphatidylinositol-3-kinase |
| PKC | Protein Kinase C |
| PNEI | Psycho-neuro-endocrino-immunology |
| PPAR-α | proliferator-activated alpha |
| PPAR-γ | proliferator-activated gamma |
| PPMS | Primary progressive MS |
| PP2A | Protein phosphatase 2A |
| PS1 | Presenilin 1 |
| PTEN | Phosphatase and TENsin homolog |
| RCT | Randomized controlled trial |
| RNS | Reactive nitrogen species |
| ROS | Reactive oxygen species |
| RRMS | Relapsing–remitting multiple sclerosis |
| SAM | S-adenosylmethionine |
| SOD | superoxide dismutase |
| SPMS | Secondary progressive multiple sclerosis |
| TBI | Traumatic brain injury |
| THF | Tetrahydrofolate |
| TLR-4 | Toll-like receptor 4 |
| TNF-α | Tumor necrosis factor α |
| TrkB | Tropomyosin receptor kinase |
| UK | United Kingdom |
| VAS | Visual analogue scale |
| WHO | World Health Organization |
| β-CTF | β-secretase-derived carboxy-terminal fragment |